Analysts Set Expectations for MDGL FY2026 Earnings
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Madrigal Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the biopharmaceutical company will earn ($2.78) per share for the year. The consensus estimate for Madrigal Pharmaceuticals’ […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Madrigal Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the biopharmaceutical company will earn ($2.78) per share for the year. The consensus estimate for Madrigal Pharmaceuticals’ […]
-sa-logo-1200x675.png?v=20240109092235&w=240&h=240&zc=2){kind=logo}
